Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the United States is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: HHSN272201300019C
Wellcome Trust
Grant: 360G-Wellcome-101999/Z/13/Z
U.S. Department of Health and Human Services
Grant: HHSO100201900007C
U.S. Department of Veterans Affairs
Grant: BX002872
Wellcome Trust
Grant: 101999/Z/13/Z
BLRD VA
Grant: I01 BX002872
NIAID NIH HHS
Grant: HHSN272201300019I
Wellcome Trust
Grant: 101999
Development of Pan -beta-lactamase inhibitors (Pan-BLIs) with activity against both serine- and metallo-beta-lactamases, including SHV, CTX-M, KPC, OXA, VIM and NDM-1.
Wellcome Trust
Cystic Fibrosis Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals